(V005) Combowire

Device Philips Electronics North America Corporation
Total Payments
$610,459
Transactions
14
Doctors
0
Companies
2

Payment Trends by Year

Year Amount Transactions Doctors
2024 $1,500 1 0
2023 $77,688 2 0
2022 $531,271 11 0

Payments by Nature

Nature of Payment Amount Transactions Share
Unspecified $610,459 14 100.0%

Research Studies & Clinical Trials

Study Name Sponsor Amount Doctors
Safe STEMI Philips Electronics North America Corporation $350,000 0
Phase II study testing the feasability and efficacy of coronary sinus narrowing in patients with coroary microvascular dysfunction Philips Electronics North America Corporation $176,987 0
Functional Coronary Angiography (FCA) Testing Protocol Project Philips Electronics North America Corporation $50,000 0
Functional Coronary Angiography (FCA) Testing Protocol Project Philips Electronics North America Corporation $25,000 0
Freedom Philips Electronics North America Corporation $6,972 0
Functional Coronary Angiography (FCA)Testing Protocol Project Philips North America LLC $1,500 0

Top Doctors Receiving Payments for (V005) Combowire

Doctor Specialty Location Total Records
Unknown Durham, NC $610,459 14

About (V005) Combowire

(V005) Combowire is a device associated with $610,459 in payments to 0 healthcare providers, recorded across 14 transactions in the CMS Open Payments database. The primary manufacturer is Philips Electronics North America Corporation.

Payment data is available from 2022 to 2024. In 2024, $1,500 was paid across 1 transactions to 0 doctors.

The most common payment nature for (V005) Combowire is "Unspecified" ($610,459, 100.0% of total).

(V005) Combowire is associated with 6 research studies, including "Safe STEMI" ($350,000).